BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027]
URL: https://www.wjgnet.com/2150-5330/full/v22/i26/6027.htm
Number Citing Articles
1
Viola Neudecker, Xiaoyi Yuan, Jessica L. Bowser, Holger K. Eltzschig. MicroRNAs in mucosal inflammationJournal of Molecular Medicine 2017; 95(9): 935 doi: 10.1007/s00109-017-1568-7
2
Karla A. Bascuñán, Francisco Pérez-Bravo, Gabriella Gaudioso, Valentina Vaira, Leda Roncoroni, Luca Elli, Erika Monguzzi, Magdalena Araya. A miRNA-Based Blood and Mucosal Approach for Detecting and Monitoring Celiac DiseaseDigestive Diseases and Sciences 2020; 65(7): 1982 doi: 10.1007/s10620-019-05966-z
3
Mohammad Mirzakhani, Ali Khalili, Mehdi Shahbazi, Saeid Abediankenari, Soheil Ebrahimpour, Mousa Mohammadnia-Afrouzi. Under-expression of microRNA-146a and 21 and their association with Crohn’s diseaseIndian Journal of Gastroenterology 2020; 39(4): 405 doi: 10.1007/s12664-020-01059-2
4
Seyed Shahabeddin Mortazavi-Jahromi, Mona Aslani, Abbas Mirshafiey. A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseasesImmunology Letters 2020; 227: 8 doi: 10.1016/j.imlet.2020.07.008
5
Soudeh Ghafouri-Fard, Reyhane Eghtedarian, Mohammad Taheri. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel diseaseBiomedicine & Pharmacotherapy 2020; 129: 110507 doi: 10.1016/j.biopha.2020.110507
6
Xiangjun Xiao, Xiangbing Mao, Daiwen Chen, Bing Yu, Jun He, Hui Yan, Jianping Wang. miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel DiseaseFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.868229
7
Alexandros Ο. Konstantinidis, Dimitra Pardali, Katerina K. Adamama-Moraitou, Maria Gazouli, Chrysostomos I. Dovas, Evangelia Legaki, Georgia D. Brellou, Ioannis Savvas, Albert E. Jergens, Timoleon S. Rallis, Karin Allenspach. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel diseaseBMC Veterinary Research 2020; 16(1) doi: 10.1186/s12917-020-02287-6
8
Frank Tacke, Martina E. Spehlmann, Mihael Vucur, Fabian Benz, Mark Luedde, David Vargas Cardenas, Sanchari Roy, Sven Loosen, Hans-Joerg Hippe, Norbert Frey, Christian Trautwein, Alexander Koch, Christoph Roderburg, Tom Luedde. miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 YearsMediators of Inflammation 2019; 2019: 1 doi: 10.1155/2019/6714080
9
Jaslin P. James, Lene Buhl Riis, Mikkel Malham, Estrid Høgdall, Ebbe Langholz, Boye S Nielsen. MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated CancerInternational Journal of Molecular Sciences 2020; 21(21): 7893 doi: 10.3390/ijms21217893
10
Tommaso Innocenti, Elisabetta Bigagli, Erica Nicola Lynch, Andrea Galli, Gabriele Dragoni. MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?Inflammatory Bowel Diseases 2022;  doi: 10.1093/ibd/izac122
11
Esmerina Tili, Jean-Jacques Michaille, Victoria Piurowski, Brooke Rigot, Carlo M Croce. MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers — their effects and therapeutic potentialsCurrent Opinion in Pharmacology 2017; 37: 142 doi: 10.1016/j.coph.2017.10.010
12
Long-Yuan Zhou, Si-Nan Lin, Florian Rieder, Min-Hu Chen, Sheng-Hong Zhang, Ren Mao. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn’s Disease: The Path From Bench to BedsideInflammatory Bowel Diseases 2021; 27(7): 971 doi: 10.1093/ibd/izaa321
13
Petr Jabandziev, Julia Bohosova, Tereza Pinkasova, Lumir Kunovsky, Ondrej Slaby, Ajay Goel. The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2020; 26(7): 985 doi: 10.1093/ibd/izaa009
14
Suruchi K Batra, Christopher R Heier, Lina Diaz-Calderon, Christopher B Tully, Alyson A Fiorillo, John van den Anker, Laurie S Conklin. Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2020; 26(10): 1597 doi: 10.1093/ibd/izaa209
15
Ayelén D. Rosso, Pablo Aguilera, Sofía Quesada, Florencia Mascardi, Sebastian N. Mascuka, María C. Cimolai, Jimena Cerezo, Renata Spiazzi, Carolina Conlon, Claudia Milano, Gregorio M. Iraola, Alberto Penas-Steinhardt, Fiorella S. Belforte. Comprehensive Phenotyping in Inflammatory Bowel Disease: Search for Biomarker Algorithms in the Transkingdom Interactions ContextMicroorganisms 2022; 10(11): 2190 doi: 10.3390/microorganisms10112190
16
Reza Yarani, Ali Shojaeian, Oana Palasca, Nadezhda T. Doncheva, Lars Juhl Jensen, Jan Gorodkin, Flemming Pociot. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s DiseaseFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.865777
17
Guanqun Chao, Yingying Wang, Fangxu Ye, Shuo Zhang. Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by TongxieyaofangYonsei Medical Journal 2018; 59(8): 945 doi: 10.3349/ymj.2018.59.8.945
18
Jennifer Bermick, Matthew Schaller. Epigenetic regulation of pediatric and neonatal immune responsesPediatric Research 2022; 91(2): 297 doi: 10.1038/s41390-021-01630-3